GB Sciences, Inc. (OTCMKTS:GBLX – Get Free Report) shares passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $0.00 and traded as high as $0.00. GB Sciences shares last traded at $0.00, with a volume of 35,585 shares changing hands.
GB Sciences Price Performance
About GB Sciences
GB Sciences, Inc, a phytomedical research and biopharmaceutical drug development company, engages in the research and development of plant-based medicines. The company offers cannabinoid-inspired medicines and complex therapeutic mixtures for the prescription drug market. Its intellectual property covers a range of medical conditions and programs in pre-clinical animal stage for Parkinson's disease, neuropathic pain, chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular therapeutic programs.
See Also
- Five stocks we like better than GB Sciences
- Investing in Construction Stocks
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- Why Are Stock Sectors Important to Successful Investing?
- How Do Stock Buybacks Affect Shareholders?
- What is the MACD Indicator and How to Use it in Your Trading
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for GB Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GB Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
-2027-municipal-bond-etf-logo-1200x675.jpg?v=20230510111730&h=45&w=95&zc=2){kind=logo}
